These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32901091)

  • 1. Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer's disease model.
    Fernandez-Valenzuela JJ; Sanchez-Varo R; Muñoz-Castro C; De Castro V; Sanchez-Mejias E; Navarro V; Jimenez S; Nuñez-Diaz C; Gomez-Arboledas A; Moreno-Gonzalez I; Vizuete M; Davila JC; Vitorica J; Gutierrez A
    Sci Rep; 2020 Sep; 10(1):14776. PubMed ID: 32901091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice.
    Zhang B; Carroll J; Trojanowski JQ; Yao Y; Iba M; Potuzak JS; Hogan AM; Xie SX; Ballatore C; Smith AB; Lee VM; Brunden KR
    J Neurosci; 2012 Mar; 32(11):3601-11. PubMed ID: 22423084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
    Brunden KR; Zhang B; Carroll J; Yao Y; Potuzak JS; Hogan AM; Iba M; James MJ; Xie SX; Ballatore C; Smith AB; Lee VM; Trojanowski JQ
    J Neurosci; 2010 Oct; 30(41):13861-6. PubMed ID: 20943926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies.
    Brunden KR; Ballatore C; Lee VM; Smith AB; Trojanowski JQ
    Biochem Soc Trans; 2012 Aug; 40(4):661-6. PubMed ID: 22817712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of microtubules improves cognitive functions and axonal transport of mitochondria in Alzheimer's disease model mice.
    Guo B; Huang Y; Gao Q; Zhou Q
    Neurobiol Aging; 2020 Dec; 96():223-232. PubMed ID: 33039900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.
    Barten DM; Fanara P; Andorfer C; Hoque N; Wong PY; Husted KH; Cadelina GW; Decarr LB; Yang L; Liu V; Fessler C; Protassio J; Riff T; Turner H; Janus CG; Sankaranarayanan S; Polson C; Meredith JE; Gray G; Hanna A; Olson RE; Kim SH; Vite GD; Lee FY; Albright CF
    J Neurosci; 2012 May; 32(21):7137-45. PubMed ID: 22623658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-beta induced retrograde axonal degeneration in a mouse tauopathy model.
    Nishioka C; Liang HF; Barsamian B; Sun SW
    Neuroimage; 2019 Apr; 189():180-191. PubMed ID: 30630081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease.
    Yao Y; Muench M; Alle T; Zhang B; Lucero B; Perez-Tremble R; McGrosso D; Newman M; Gonzalez DJ; Lee VM; Ballatore C; Brunden KR
    Alzheimers Dement; 2024 Jul; 20(7):4540-4558. PubMed ID: 38884283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D.
    Penazzi L; Tackenberg C; Ghori A; Golovyashkina N; Niewidok B; Selle K; Ballatore C; Smith AB; Bakota L; Brandt R
    Neuropharmacology; 2016 Jun; 105():84-95. PubMed ID: 26772969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies.
    Brunden KR; Yao Y; Potuzak JS; Ferrer NI; Ballatore C; James MJ; Hogan AM; Trojanowski JQ; Smith AB; Lee VM
    Pharmacol Res; 2011 Apr; 63(4):341-51. PubMed ID: 21163349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
    Baazaoui N; Iqbal K
    J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice.
    Di Meco A; Joshi YB; Lauretti E; Praticò D
    Mol Psychiatry; 2016 Mar; 21(3):403-10. PubMed ID: 26077691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy.
    Makani V; Zhang B; Han H; Yao Y; Lassalas P; Lou K; Paterson I; Lee VM; Trojanowski JQ; Ballatore C; Smith AB; Brunden KR
    Acta Neuropathol Commun; 2016 Sep; 4(1):106. PubMed ID: 27687527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of microtubule defects within Aβ plaque-associated dystrophic axons results in lowered Aβ release and plaque deposition.
    Yao Y; Nzou G; Alle T; Tsering W; Maimaiti S; Trojanowski JQ; Lee VM; Ballatore C; Brunden KR
    Alzheimers Dement; 2020 Oct; 16(10):1345-1357. PubMed ID: 32918367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.